Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Vaxart to present new data from Phase 2 Challenge Study of H1 influenza oral tablet vaccine

Vaxart to present new data from Phase 2 Challenge Study of H1 influenza oral tablet vaccine

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

Special glowing paper strip as rapid, reliable test for infectious diseases

Special glowing paper strip as rapid, reliable test for infectious diseases

Genentech announces clinical data from studies investigating risdiplam in spinal muscular atrophy

Genentech announces clinical data from studies investigating risdiplam in spinal muscular atrophy

Penn scientists to explore new approach for predicting and treating diseases at individual level

Penn scientists to explore new approach for predicting and treating diseases at individual level

Aggressive breast cancer hijacks normal protective physiological process to survive

Aggressive breast cancer hijacks normal protective physiological process to survive

Scientists perform successful trial of new antibiotic on cancer reoccurrence after surgery

Scientists perform successful trial of new antibiotic on cancer reoccurrence after surgery

Immune protein 'flutters' like a butterfly in search of viruses, finds study

Immune protein 'flutters' like a butterfly in search of viruses, finds study

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

Scientists investigate effect of flu-causing virus on three lung-derived cell lines

Scientists investigate effect of flu-causing virus on three lung-derived cell lines

Medicare eases readmission penalties against safety-net hospitals

Medicare eases readmission penalties against safety-net hospitals

Critical illness and major infection can promote brain changes, accelerate cognitive decline

Critical illness and major infection can promote brain changes, accelerate cognitive decline

Verastem Oncology selects US Bioservices to dispense COPIKTRA capsules

Verastem Oncology selects US Bioservices to dispense COPIKTRA capsules

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Parents are leery of schools requiring ‘mental health’ disclosures by students

Parents are leery of schools requiring ‘mental health’ disclosures by students

Fina Biosolutions receives patent for expression and purification of the conjugate vaccine protein

Fina Biosolutions receives patent for expression and purification of the conjugate vaccine protein

Updated model of PAXMAN Scalp Cooling System launched

Updated model of PAXMAN Scalp Cooling System launched

GARDP partners with Novartis to accelerate development of generic antibiotic treatments for children

GARDP partners with Novartis to accelerate development of generic antibiotic treatments for children

Scientists discover most important target of MRSA bacterial toxin and ways to neutralize it

Scientists discover most important target of MRSA bacterial toxin and ways to neutralize it

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.